Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Redx Pharma
Redx Pharma
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Andelyn Biosciences and Grace Science, LLC partner to manufacture AAV gene therapy
The partnership will seek to maximise programme efficiency, support the ongoing clinical trial and accelerate this critical therapy to patients
Teva UK and Closed Loop Medicine partner to advance personalised medicine development
SaMD platform aims to advance personalised medicine development, improve drug efficacy and patient outcomes with specific chronic conditions
Henkel facilities receive EXCiPACT certificate as suppliers of pharmaceutical excipients
The certification means Henkel meets EXCiPACT’s guidelines for good manufacturing practice (GMP) and good distribution practice (GDP)
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Ingredients
Redx signs licensing agreement with AstraZeneca for porcupine inhibitor
AstraZeneca will take RXC006 forward into clinical development, targeting fibrotic diseases including idiopathic pulmonary fibrosis
Finance
Redx Pharma appoints Sarah Gordon as non-executive Director
Gordon has been appointed due to deep experience of the biotechnology industry and capital markets
Research & Development
Redx Pharma announces new drug development candidate for fibrosis
First-in-human studies earmarked for 2020
Research & Development
Quay Pharma to supply promising cancer drug for trial
Quay Pharma has reached an agreement with Redx Pharma to manufacture Redx’s breakthrough cancer treatment drug
Research & Development
Redx Pharma set for new HQ at Alderley Park, Cheshire
Will bring together its three subsidiaries Redx Oncology, Redx Anti-Infectives and Redx Immunology onto one site
Research & Development
Redx Pharma launches £24m immunology R&D centre
Receives £4.2m of funding from the UK Government's Regional Growth Fund to be matched with proceeds from AIM listing
Research & Development
Redx Pharma and Pierre Fabre collaborate in skin cancer drug field
Will together develop a small molecule programme for an undisclosed cancer target
Subscribe now